The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia

Gut

Volumn 65, Issue 4, 2016, Pages 575-583

  Schuijt, Tim J ^a,b   Lankelma, Jacqueline M ^a   Scicluna, Brendon P ^a   De Sousa E Melo, Felipe ^a   Roelofs, Joris J T H ^a   De Boer, J Daan ^a   Hoogendijk, Arjan J ^a   De Beer, Regina ^a   De Vos, Alex ^a   Belzer, Clara ^c   De Vos, Willem M ^c,d   Van Der Poll, Tom ^a   Wiersinga, W Joost ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b DEPARTMENT OF SURGERY   (Netherlands)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; TRANSCRIPTOME; TUMOR NECROSIS FACTOR ALPHA; ANTIINFECTIVE AGENT; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL COUNT; CONTROLLED STUDY; FECAL MICROBIOTA TRANSPLANTATION; GENOME ANALYSIS; HOST RESISTANCE; INFLAMMATION; INTESTINE FLORA; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE FUNCTION; MORTALITY; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SEPSIS; STREPTOCOCCUS PNEUMONIA; SURVIVAL RATE; TISSUE INJURY; UPREGULATION; ANIMAL; BACTERIAL LOAD; C57BL MOUSE; FECES; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MUCOSAL IMMUNITY; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL LOAD; FECES; GASTROINTESTINAL MICROBIOME; IMMUNITY, MUCOSAL; INTERLEUKIN-10; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED C57BL; PNEUMONIA, PNEUMOCOCCAL; SEPSIS; STREPTOCOCCUS PNEUMONIAE; TRANSCRIPTOME; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84946854837     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2015-309728     Document Type: Article

References (37)

1. Wunderink RG, Waterer GW. Clinical practice. Community-acquired pneumonia. N Engl J Med 2014; 370: 543-51.
2. Nair H, Simoes EA, Rudan I, et al. Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis. Lancet 2013; 381: 1380-90.
3. van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 2009; 374: 1543-56.
4. Dockrell DH, Whyte MK, Mitchell TJ. Pneumococcal pneumonia: mechanisms of infection and resolution. Chest 2012; 142: 482-91.
5. Clark JA, Coopersmith CM. Intestinal crosstalk: a new paradigm for understanding the gut as the "motor" of critical illness. Shock 2007; 28: 384-93.
6. Clemente JC, Ursell LK, Parfrey LW, et al. The impact of the gut microbiota on human health: an integrative view. Cell 2012; 148: 1258-70.
7. Clarke TB, Davis KM, Lysenko ES, et al. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med 2010; 16: 228-31.
8. Noverr MC, Huffnagle GB. Does the microbiota regulate immune responses outside the gut? Trends Microbiol 2004; 12: 562-8.
9. Schuijt TJ, van der Poll T, de Vos WM, et al. The intestinal microbiota and host immune interactions in the critically ill. Trends Microbiol 2013; 21: 221-9.
10. Backhed F, Fraser CM, Ringel Y, et al. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe 2012; 12: 611-22.
11. Trompette A, Gollwitzer ES, Yadava K, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 2014; 20: 159-66.
12. Deshmukh HS, Liu Y, Menkiti OR, et al. The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice. Nat Med 2014; 20: 524-30.
13. Caballero S, Pamer EG. Microbiota-mediated inflammation and antimicrobial defense in the intestine. Annu Rev Immunol 2015; 33: 227-56.
14. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA 2011; 108(Suppl. 1): 4554-61.
15. Strieter RM, Belperio JA, Keane MP. Cytokines in innate host defense in the lung. J Clin Invest 2002; 109: 699-705.
16. Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature 2011; 473: 174-80.
17. Rajilic-Stojanovic M, Heilig HG, Molenaar D, et al. Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ Microbiol 2009; 11: 1736-51.
18. Serezani CH, Aronoff DM, Sitrin RG, et al. FcgammaRI ligation leads to a complex with BLT1 in lipid rafts that enhances rat lung macrophage antimicrobial functions. Blood 2009; 114: 3316-24.
19. Kannan S, Audet A, Huang H, et al. Cholesterol-rich membrane rafts and Lyn are involved in phagocytosis during Pseudomonas aeruginosa infection. J Immunol 2008; 180: 2396-408.
20. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013; 369: 2063.
21. Blaser M, Bork P, Fraser C, et al. The microbiome explored: recent insights and future challenges. Nat Rev Microbiol 2013; 11: 213-17.
22. Clarke TB Early innate immunity to bacterial infection in the lung is regulated systemically by the commensal microbiota via nod-like receptor ligands. Infect Immun 2014; 82: 4596-606.
23. Ichinohe T, Pang IK, Kumamoto Y, et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci USA 2011; 108: 5354-9.
24. Wang J, Li F, Sun R, et al. Bacterial colonization dampens influenza-mediated acute lung injury via induction of M2 alveolar macrophages. Nat Commun 2013; 4: 2106.
25. Li Q, Wang C, Tang C, et al. Therapeutic modulation and reestablishment of the intestinal microbiota with fecal microbiota transplantation resolves sepsis and diarrhea in a patient. Amer J of Gastroenter 2014; 109: 1832-4.
26. Morrow LE, Kollef MH, Casale TB. Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med 2010; 182: 1058-64.
27. Ericsson AC, Davis JW, Spollen W, et al. Effects of vendor and genetic background on the composition of the fecal microbiota of inbred mice. PLoS ONE 2015; 10: e0116704.
28. Carmody RN, Gerber GK, Luevano JM Jr, et al. Diet dominates host genotype in shaping the murine gut microbiota. Cell Host Microbe 2015; 17: 72-84.
29. Tilg H, Moschen AR. Microbiota and diabetes: an evolving relationship. Gut 2014; 63: 1513-21.
30. Rijneveld AW, Florquin S, Bresser P, et al. Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumonia. Blood 2003; 102: 934-9.
31. van der Windt GJ, Blok DC, Hoogerwerf JJ, et al. Interleukin 1 receptor-associated kinase m impairs host defense during pneumococcal pneumonia. J Infect Dis 2012; 205: 1849-57.
32. Duitman J, Schouten M, Groot AP, et al. CCAAT/enhancer-binding protein delta facilitates bacterial dissemination during pneumococcal pneumonia in a platelet-activating factor receptor-dependent manner. Proc Natl Acad Sci USA 2012; 109: 9113-18.
33. Ubeda C, Bucci V, Caballero S, et al. Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect Immun 2013; 81: 965-73.
34. Ubeda C, Taur Y, Jenq RR, et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 2010; 120: 4332-41.
35. Salonen A, Nikkila J, Jalanka-Tuovinen J, et al. Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: effective recovery of bacterial and archaeal DNA using mechanical cell lysis. J Microbiol Methods 2010; 81: 127-34.
36. Wiersinga WJ, Kager LM, Hovius JW, et al. Urokinase receptor is necessary for bacterial defense against pneumonia-derived septic melioidosis by facilitating phagocytosis. J Immunol 2010; 184: 3079-86.
37. Kager LM, Weehuizen TA, Wiersinga WJ, et al. Endogenous alpha2-antiplasmin is protective during severe gram-negative sepsis (melioidosis). Am J Respir Crit Care Med 2013; 188: 967-75.